Orthobiologics Market Report 2026

Orthobiologics Market Overview

• Orthobiologics market size has reached to $7.48 billion in 2025 • Expected to grow to $9.86 billion in 2030 at a compound annual growth rate (CAGR) of 5.6% • Growth Driver: Orthobiologics Market Growth Driven by Rising Sports Injuries and Road Accidents • Market Trend: Innovative Developments in Dry Allograft Mixtures To Enhance Bone Healing and Fusion • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Orthobiologics Market?

Orthobiologics refer to therapies derived from natural substances used to treat various musculoskeletal conditions. These therapies enhance the body's ability to repair and regenerate bones, cartilage, tendons, and ligaments in orthopedic treatments. Their goal is to improve recovery times and outcomes in procedures such as spinal fusion, fracture repair, and joint reconstruction. The main products of orthobiologics are viscosupplements, bone growth factors, demeneralized bone matrix, synthetic bone substitutes, cellular allograft, and others. Viscosupplements are gel-like substances injected into joints to provide lubrication and cushioning, reducing pain and improving mobility for individuals with osteoarthritis. They are used for various applications, including spinal fusion, maxillofacial and dental, soft tissue repair, reconstructive and fracture surgery, and others, by several end users, such as hospitals, orthopedic clinics, ambulatory surgery centers, and others.

What Is The Orthobiologics Market Growth Forecast?

The orthobiologics market size is expected to see strong growth in the next few years. It will grow to $9.86 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to expanding pipeline of cellular and exosome-based orthobiologic products, increasing investment in tissue engineering and regenerative medicine, rising adoption of minimally invasive and outpatient orthopedic procedures, growing demand for personalized and targeted orthobiologic treatments, expansion of orthobiologics use in dental and maxillofacial applications. Major trends in the forecast period include rising adoption of platelet-rich plasma (prp) and bone morphogenetic proteins (bmps), increasing use of synthetic bone substitutes for fracture repair and spinal fusion, growing preference for cellular allografts and stem cell-based therapies, rising focus on minimally invasive orthopedic procedures, increasing emphasis on accelerated recovery and improved clinical outcomes.

Global Orthobiologics Market Segmentation

1) By Product Type: Viscosupplements, Bone Growth Factors, Demineralized Bone Matrix, Synthetic Bone Substitutes, Cellular Allograft, Other Products 2) By Application: Spinal Fusion, Maxillofacial And Dental, Soft Tissue Repair, Reconstructive And Fracture Surgery, Other Applications 3) By End User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End Users Subsegments: 1) By Viscosupplements: Hyaluronic Acid Injections, Gel-Based Viscosupplements, Cross-linked Hyaluronic Acid 2) By Bone Growth Factors: Bone Morphogenetic Proteins (BMPs), Recombinant Human Bone Morphogenetic Proteins (rhBMPs), Platelet-Rich Plasma (PRP), Osteogenic Protein-1 (OP-1), Growth Factors For Bone Healing 3) By Demineralized Bone Matrix: DBM Grafts, DBM Putty, DBM Sponges, DBM Paste And Chips 4) By Synthetic Bone Substitutes: Calcium Phosphate-Based Substitutes, Calcium Sulfate-Based Substitutes, Tricalcium Phosphate (TCP), Hydroxyapatite (HA), Bioactive Glasses 5) By Cellular Allograft: Osteocellular Allografts, Mesenchymal Stem Cells (MSCs) Allografts, Bone Marrow-Derived Cellular Allografts, Adipose Tissue-Derived Cellular Allografts 6) By Other Products: Autografts, Collagen-Based Grafts, Synthetic Bone Graft Substitutes (Non-Bioactive), Amniotic Membrane-Based Grafts, Exosome-Based Products

What Is The Driver Of The Orthobiologics Market?

The increasing number of road accidents and sports injuries is expected to propel the growth of the orthobiologics market going forward. Road accidents and sports injuries refer to incidents causing physical harm to individuals, often involving the musculoskeletal system. Road accidents and sports injuries are fueled by factors such as distracted driving, speeding, poor road conditions for accidents, overuse, improper equipment, and lack of proper training for sports injuries. Orthobiologics help in the treatment of road accidents and sports injuries by promoting faster and more effective healing of musculoskeletal tissues, reducing inflammation, and enhancing the body's natural repair processes through the use of substances such as bone grafts, growth factors, stem cells, and platelet-rich plasma. For instance, in July 2025, according to a report published by the Bureau of Infrastructure and Transport Research Economics (BITRE), an Australia-based government agency, there were 1,340 road deaths, which is a 2.9% increase compared to the 12 months ending July 2024. Therefore, the increasing number of sports injuries and road accidents will drive the orthobiologics industry.

Key Players In The Global Orthobiologics Market

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

Global Orthobiologics Market Trends and Insights

Major companies operating in the orthobiologics market are developing advanced solutions, such as dry allograft mixtures, to enhance bone healing and fusion in orthopedic procedures. Dry allograft mixtures integrate robust cortical fibers with mineralized cortical bone, providing structural support and promoting osteoinductive properties that aid in new bone formation. For instance, in May 2024, Isto Biologics, a US-based biologics-focused company, launched Fibrant Liberty allograft, a dry allograft mixture that integrates robust cortical fibers with mineralized cortical cancellous chips. Upon hydration, the graft becomes pliable and can be customized for various surgical procedures. The longer and stronger fibers enhance handling and form an intricate network that prevents graft migration while maintaining structural integrity.

What Are Latest Mergers And Acquisitions In The Orthobiologics Market?

In February 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, acquired Embody Inc. for $155 million. With this acquisition, Zimmer aims to invest in areas with high growth potential and to demonstrate its commitment to introducing important innovations to benefit patients and surgeons. The acquisition includes Embody's complete portfolio of collagen-based biointegrative solutions to support healing in the most challenging orthopedic soft tissue injuries. Embody is a US-based soft tissue healing company that specializes in the development and manufacturing of collagen-based biologic products for soft tissue augmentation and repair.

Regional Outlook

North America was the largest region in the orthobiologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Orthobiologics Market?

The orthobiologics market consists of sales of bone morphogenetic proteins, hyaluronic acid, stem cells, and platelet-rich plasma. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Orthobiologics Market Report 2026?

The orthobiologics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the orthobiologics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.